FindTrial
Sign In

comparative between butorphanol and nalbuphine as to adjuvants to spinal bupivacaine in infra umbilical surgeries

comparative study of butorphanol vs nalbuphine as adjuvants to intrathecal bupivacaine in infra umbilical surgeries:prospective randomised double blind study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/04/018408
Enrollment
120
Registered
2019-04-03
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K409- Unilateral inguinal hernia, without obstruction or gangrene

Interventions

Intervention1: Butorphanol: As an adjuvant to Subarachanoid Block Intervention2: Nalbuphine: As an adjuvant to Subarachanoid Block Intervention3: Butorphenol 25mcg Nalbuphine 300mcg: Adjuvant in Sub a

Sponsors

Yawanth Reddy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients posted for lower abdominal, lower limb surgeries under spinal anaesthesia

Exclusion criteria

Exclusion criteria: Patients allergic to local anaesthetics, nalbuphine/ Butorphanol ASA physical status III or more Height 30 kg/m2 Patient contraindicated for spinal anaesthesia Patient who had acute and chronic pain elements Patient refusal

Design outcomes

Primary

MeasureTime frame
To compare the duration of analgesia in terms of time to first analgesic requirement. Timepoint: Postoperatively—

Secondary

MeasureTime frame
To compare quality of analgesia measured in terms of total analgesic requirement . To compare pain scores, duration of motor blockade, perioperative hemodynamic parameters. To study the incidence of opioid related side effects in the two groups Timepoint: intra operatively and Postoperatively—

Countries

India

Contacts

Public ContactYaswanth Reddy

Shri Sathya Sai Medical College and Research Institute

esenkeyem@gmail.com9786743120

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026